Reduced pulmonary clearance of endothelin-1 contributes to the increase of circulating levels in heart failure secondary to myocardial infarction

Circulation. 1998 Oct 20;98(16):1684-7. doi: 10.1161/01.cir.98.16.1684.

Abstract

Background: The pulmonary vascular bed is a major site for endothelin-1 (ET-1) clearance. A reduced clearance could contribute to the increase in circulating ET-1 levels found in heart failure (HF). We therefore evaluated the effect of HF on pulmonary ET-1 clearance and on plasma ET-1 concentrations.

Methods and results: Rats with myocardial infarction (n=24) were compared with sham-operated rats (n=22). The lungs were isolated and perfused at a constant flow rate of 10 mL/min. Pulmonary ET-1 clearance was measured by the single-bolus indicator-dilution technique with 125I-labeled ET-1. Infarct rats developed HF with mild pulmonary hypertension. ET-1 extraction was reduced by HF from 63+/-1.5% to 41+/-4.5% (mean+/-SEM, P<0.001). Mixed venous (MV) and aortic ET-1 levels doubled with HF. There was a plasma ET-1 gradient across the lungs of sham rats (MV-aortic levels, 0.21+/-0.12 pg/mL) but not in lungs of HF rats (0.01+/-0.17 pg/mL). Plasma ET-1 levels correlated closely and inversely with ET-1 extraction (P<0.001).

Conclusions: HF is associated with reduced pulmonary ET-1 clearance that contributes to the increase in circulating levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiac Output, Low / blood*
  • Cardiac Output, Low / etiology
  • Endothelin-1 / blood
  • Endothelin-1 / pharmacokinetics*
  • Lung / blood supply
  • Lung / metabolism*
  • Male
  • Metabolic Clearance Rate
  • Myocardial Infarction / blood*
  • Myocardial Infarction / complications
  • Rats
  • Rats, Wistar

Substances

  • Endothelin-1